Accumulating data point to K þ channels as relevant players in controlling cell cycle progression and proliferation of human cancer cells, including prostate cancer (PCa) cells. However, the mechanism(s) by which K þ channels control PCa cell proliferation remain illusive. In this study, using the techniques of molecular biology, biochemistry, electrophysiology and calcium imaging, we studied the expression and functionality of intermediate-conductance calcium-activated potassium channels (IK Ca1 ) in human PCa as well as their involvement in cell proliferation. We showed that IK Ca1 mRNA and protein were preferentially expressed in human PCa tissues, and inhibition of the IK Ca1 potassium channel suppressed PCa cell proliferation. The activation of IK Ca1 hyperpolarizes membrane potential and, by promoting the driving force for calcium, induces calcium entry through TRPV6, a cation channel of the TRP (Transient Receptor Potential) family. Thus, the overexpression of the IK Ca1 channel is likely to promote carcinogenesis in human prostate tissue.
Introduction
Prostate cancer (PCa) is a leading cause of cancerrelated deaths in western countries (Woolf, 1995) . Standard therapies include androgen ablation, which causes tumor regression. However, the disease often relapses, in the form of a hormone-refractory tumor that no longer responds to conventional therapies (Isaacs, 1994) . In the context of this need for new approaches and drug targets, we have investigated the role of the intermediate-conductance Ca 2 þ -activated K þ channels (IK Ca1 ) in PCa. Accumulating data from a variety of cell types have shown that potassium channels are essential for cell proliferation and appear to play a role in carcinogenesis (Kunzelmann, 2005; . Among the known K þ channels, EAG1, a member of the ether-ago-go (EAG) subfamily, has been studied in greatest detail, as it has been found to have an oncogenic potential in several human cancers (Pardo et al., 1999; Pardo and van Duijn, 2005; Hemmerlein et al., 2006) . However, Ca 2 þ -dependent potassium channels (K Ca ) are also involved in cancer-related mechanisms and are attracting increasing attention (Ghanshani et al., 2000; Ouadid-Ahidouch et al., 2001) . Intermediate-conductance Ca 2 þ -activated K þ channels, IK Ca1 (also called IK1, SK4, hSK4, hKCa4 and KCa3.1), are of particular interest, as their expression has been shown to increase in activated T lymphocytes (Ghanshani et al., 2000) and pancreatic cancer cells (Jager et al., 2004) and undergo modulation during the cell cycle in breast cancer cells (Ouadid-Ahidouch et al., 2004) . Pharmacological data also indicate the presence of IK Ca1 in PCa cells. Indeed, 86 Rb þ efflux and enhanced cell proliferation induced in LNCaP and PC-3 cells by an IK Ca1 channel activator (1-ethyl-2-benzimidazolinone (1-EBIO)) was inhibited by IK Ca1 channel blockers (Parihar et al., 2003) . In this study, we investigated the expression of IK Ca1 in PCa and the mechanism by which it regulates the intracellular calcium concentration and cell proliferation.
Results

IK Ca1 potassium channel is expressed in human PCa cells
The reverse transcription-PCR (RT-PCR) technique was initially used to check the mRNA expression of the IK Ca1 potassium channel in human PCa cell lines (LNCaP, and cultured primary human PCa epithelial (hPCE) cells from tissue specimens. Analysis of RT-PCR products revealed the amplification of a single fragment of the expected size (867 bp) from the cDNA of all cell lines and hPCE cells (Figure 1a) . Further cloning and sequencing of the amplified PCR product confirmed its specificity and correspondence to the published sequence for human IK Ca1 channel mRNA.
Further studies focused on two PCa cell lines, an androgen-sensitive LNCaP and an androgen-insensitive PC-3. First, we examined IK Ca1 channel protein expression by western blot analysis of the total protein preparations of LNCaP and PC-3 cells, using a specific antibody directed against the N-terminal end of the IK Ca1 channel. To validate the specificity of the anti-IK Ca1 antibody, western blotting experiments were performed on 10 mg of the total protein extracts from HEK-293 cell lines stably transfected either by empty vector (HEK-Neo) or bearing the IK Ca1 coding cDNA (HEK-IK Ca1 ). In these experiments, the anti-IK Ca1 antibody revealed a band of about 52±2 kDa only in protein extracts from HEK-IK Ca1 cells (Figure 1b) . The expected size, according to amino-acid sequence of the channel, being 47 kDa, the differences in protein size observed may be due to post-translational modifications, for example, glycosylation and/or phosphorylations of the channel protein.
As shown in Figure 1c , the IK Ca1 antibody revealed a protein band of approximately 52 kDa in LNCaP and PC-3 cells similar to that observed in HEK-IK Ca1 cells. IK Ca1 expression at the protein level was also confirmed in both LNCaP and PC-3 PCa cell lines by immunofluorescence studies using the anti-IK Ca1 -specific antibody (data not shown).
IK Ca1 is overexpressed in PCa tissues IK Ca1 expression was also studied at the mRNA level by RT-PCR and at the protein level by immunofluorescence in human tissue specimens from benign prostate hyperplasia (BPH) and PCa. Of a total of 19 PCa tissues and 22 BPH tissues used in these studies, the IK Ca1 mRNA was expressed in 89.5% (17 out of 19) of PCa tissues and in 18% (4 out of 22) of BPH tissues, suggesting a preferential expression of the IK Ca1 in PCa tissues. To ensure that the absence of the IK Ca1 expression in BPH tissues used in this study is not due to the absence of the epithelial cells, we also searched for the expression of the apical epithelial cell marker, the cytokeratin 18. As shown in Supplementary information, Figure 1b , cytokeratin 18 is expressed at a comparable level in all samples used for this study, whereas IK Ca1 is expressed preferentially in PCa tissues. To confirm these observations, we studied the expression of the channel protein in three BPH and five PCa formalin-fixed, paraffin-embedded tissues using the IK Ca1 -specific antibody. As shown in Figure 1e , the IK Ca1 protein was highly expressed in epithelial cells of grade 3 (Figure 1e ) and grade 4 (Figure 1f ) PCa tissues, whereas a very faint labeling was observed in the stromal cells. In BPH samples, the expression of the IK Ca1 was either absent or very low compared with that in PCa tissues. However, in some BPH sections, a clear IK Ca1 labeling was observed in the pluri-stratified epithelial cells (Figure 1e, BPH) , an aspect caused due to the high proliferation activity of the acinar cells in which IK Ca1 may play a major role. These studies show clearly the overexpression of IK Ca1 in PCa and confirm the data obtained in the RT-PCR studies presented in Figure 1d .
Ca
2 þ -induced activation of IK Ca1 channels hyperpolarizes human PCa cell membrane potential The patch-clamp technique in whole-cell configuration was used to study the functionality of IK Ca1 and its involvement in the modulation of the membrane potential in LNCaP cells. First, we examined the impact of an increase in intracellular free calcium concentration on the membrane potential in these cells. To address this aspect, combined current-clamp and calcium-imaging experiments in perforated patch-clamp configurations were performed. To artificially increase the intracellular free calcium concentration ([Ca 2 þ ] i ), we used thapsigargin (TG), which inhibits the endoplasmic reticulum SERCA Ca 2 þ pump, causing calcium mobilization from intracellular stores followed by store-operated calcium entry in PCa cells (Skryma et al., 2000) .
As shown in Figure 2a , the TG-induced increase in [Ca 2 þ ] i was accompanied by a large hyperpolarization of membrane potential. The average resting membrane potential of LNCaP cells, À47±8 mV, shifted to À71 ± 2.7 mV following TG application. To study the involvement of the IK Ca1 functionality in the TGinduced membrane hyperpolarization, the following experiments were performed. Using electrophysiological techniques of patch clamp in whole-cell configuration, we examined the impact of an increase in intracellular calcium on potassium current activation. A voltage ramp of À150 to þ 100 mV was applied to the LNCaP cells and the resulting currents were recorded. Figure 2b shows typical recording acquired in an LNCaP cell under control conditions (CTL) and after the application of TG (100 nM). In control conditions, only outward and voltage-dependent currents were observed at all membrane potentials above À30 mV as described by Skryma et al. (1997 Skryma et al. ( , 1999 ). An increase in intracellular free calcium concentration by the application of TG (100 nM) induced the development of an additional potassium current due to the activation of K Ca channels. The currents recorded after TG applications were K þ selective, as could be seen from their mean reversal potential (E rev ) of À80 ± 5 mV (n ¼ 32) (Nernst potential of K þ (E K ) ¼ À80 mV). To study the involvement of the IK Ca1 channels in the calcium-activated potassium currents (I KCa ) observed in response to TG, we used two known inhibitors of this channel, clotrimazole (CLT) and a modified CLT molecule, 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34), developed 2004). As shown in Figure 2b , the application of CLT (10 mM) inhibited the TG-induced I KCa current by about 72% at þ 100 mV and 100% at À150 mV. The residual CLT-insensitive I KCa was probably mediated by the large-conductance potassium channel (BK Ca ), as the mRNA and the protein for this channel were also detected in LNCaP cells (data not shown).
To confirm the functionality of IK Ca1 in LNCaP cells in electrophysiological studies, we used a specific pharmacological tool, 1-EBIO, known to activate both heterologously expressed (Pedersen et al., 1999; von Hahn et al., 2001 ) and native IK Ca1 channels (Devor et al., 1996; Khanna et al., 1999) . In these studies, the concentration of the free calcium in the pipette solution was 200 nM and a voltage ramp of À150 to þ 40 mV was applied. The resulting currents were recorded in the absence (CTL) or in the presence of 1-EBIO in the extracellular medium. As shown in Figure  2c and d, 1-EBIO (200 mM) induced K þ currents similar to those developed in the presence of TG in LNCaP cells. Moreover, the 1-EBIO-induced currents were blocked by CLT (10 mM) (Figure 2c ) and dose dependently by 5 and 10 mM TRAM-34 (Figure 2d ), whereas the apamin (500 nM), an inhibitor of the SK family of the K Ca channels, and TEA (5 mM), an inhibitor known to block BK Ca channel, were without effect on the 1-EBIO-elicited K þ currents (data not shown). In addition to these studies conducted using the pharmacological tools , the specificity of 1-EBIO effects to activate IK Ca1 was verified by using small interfering RNA (siRNA) targeting IK Ca1 as presented in Supplementary information (Figure 3b ). A voltage ramp of À150 to þ 100 mV was applied to the LNCaP cells and the resulting current (I) recorded under control (CTL) conditions and after the increase in intracellular free calcium concentration triggered by TG application (100 nM). To study the involvement of IK Ca1 in the calcium-induced potassium currents in LNCaP cells, following TG-induced potassium current developments, the effects of CLT (10 mM), an IK Ca1 inhibitor, were studied. To confirm the functionality of the IK Ca1 channels in LNCaP cells, IK Ca1 currents were elicited by the application of the IK Ca1 activator 1-EBIO (200 mM) (c and d) and then pharmacological inhibitors, CLT (10 mM) (c) or TRAM-34 (5 and 10 mM) (d), were used to block the IK Ca1 current. To study the involvement of IK Ca1 in the calcium-induced hyperpolarization of membrane potential in LNCaP cells, membrane potential was measured before and after the application of either TG (100 nM) (e) or 1-EBIO (200 mM) (f). Following TG-or 1-EBIO-induced hyperpolarization, CLT (10 mM) was applied. In both cases, hyperpolarization was completely reversed (n ¼ 9) when CLT (10 mM) was applied. CLT, clotrimazole; 1-EBIO, 1-ethyl-2-benzimidazolinone; IK Ca1 , intermediate-conductance calcium-activated potassium channel; TG, thapsigargin.
To characterize the functional role of IK Ca1 channels in the control of membrane potential, we performed current-clamp experiments. To test whether IK Ca1 activation was involved in the Ca 2 þ -induced hyperpolarization, membrane potential was measured before and after the TG-induced increase in [Ca 2 þ ] i . Application of TG (100 nM) induced sustained hyperpolarization of the membrane potential ( Figure 2e ). In the presence of 10 mM CLT (n ¼ 9), membrane hyperpolarization was completely reversed. In the same manner, an application of IK Ca1 activator, 1-EBIO (200 mM), induced sustained hyperpolarization of the membrane potential, which could be prevented by 10 mM CLT ( Figure 2f ). These data show that IK Ca1 is functional in LNCaP cells, assures the majority of the IK Ca currents in these cells and is involved in the calcium-induced modulation of the membrane potential.
Similar results showing the functionality of the IK Ca1 channel were obtained in primary cultured PCa cells (hPCE cells) by using TG to induce a [Ca 2 þ ] i increase or an IK Ca1 activator (1-EBIO) and CLT (10 mM) (Figure 3a) or TRAM-34 (1 and 10 mM) (Figure 3b ) as inhibitors of IK Ca1 (Figure 3a and b). The electrophysiological studies conducted on hPCE cells showed that the membrane potential varied between À30 and þ 20 mV with a mean value of À2.4±2.2 mV (n ¼ 45). An application of TG (100 nM) induced hyperpolarization of the membrane potential, which was reversed in the presence of 10 mM CLT (Figure 3c ). These observations suggested that the majority of the I KCa activated in PCa epithelial cells of various origins in response to an increase in [Ca 2 þ ] i was due to IK Ca1 channel activation, which was responsible for the hyperpolarization induced by an increase in [Ca 2 þ ] i .
IK Ca1 controls PCa cell proliferation
To elucidate whether IK Ca1 expression was functionally important in controlling cell growth, we tested the effect of IK Ca1 inhibitors (TRAM-34 and CLT) and siIK Ca1 on the growth rate of human PCa cell lines. As shown in Figure 2 were performed on primary cultured cells from human prostate cancer tissue (hPCE cells) to study the involvement of IK Ca1 in Ca 2 þ -activated K þ current and plasma membrane hyperpolarization. Typical traces obtained using the patch-clamp technique in whole-cell configuration as described in Materials and methods and in Figure 2 and showing the involvement of IK Ca1 in the calcium-activated K þ currents (a), 1-EBIO-induced IK Ca1 currents (b) and the involvement of the IK Ca1 in the calcium-induced membrane hyperpolarization (c) in primary cultured hPCE cells. Following TG-or 1-EBIO-induced potassium current development, CLT (10 mM) (a) or TRAM-34 (1 and 10 mM) (b) was applied. To study the involvement of IK Ca1 in the calcium-induced hyperpolarization of membrane potential in hPCE cells, membrane potential was measured before and after TG application (100 nM). Following TG-induced hyperpolarization, CLT (10 mM) was applied. TG-induced hyperpolarization was completely reversed (n ¼ 6) when CLT (10 mM) was applied. CLT, clotrimazole; 1-EBIO, 1-ethyl-2-benzimidazolinone; IK Ca1 , intermediate-conductance calcium-activated potassium channel; TG, thapsigargin. Figure 4 Blockade of IK Ca1 K þ channels inhibits prostate cancer cell proliferation and the accumulation of p21 Cip1 mRNA. Cells were trypsinized and seeded for 48 h, then treated for 4 days with either solvent (CTL) or TRAM-34 (1-30 mM), an IK Ca1 K þ channel blocker, in culture medium. Cell growth was then measured as described in Materials and methods. Results are presented as the percentage of CRL for (a) LNCaP and (e) PC-3 cells. In another set of experiments, the effects of cell transfection with either control siRNA (siCTL) or IK Ca1 -targetted siRNA (siIK Ca1 ) on cell proliferation were studied for (c) LNCaP and (g) PC-3 cells. Experiments were repeated four times in independent cell cultures and a representative figure is presented for each cell type. *Po0.001 compared with their respective controls. Typical RT-PCR analysis of p27
Kip1 and p21 Cip1 mRNA expression performed on control (CTL) and TRAM-34-treated (b) LNCaP and (f) PC-3 human prostate cancer cells. Cells were plated in culture medium in the absence (CTL) or presence of TRAM-34 (10 and 20 mM) for 3 days, and then harvested. In the same way, the effects of cell transfection with either control siRNA (siCTL) or siIK Ca1 on the expression of p27
Kip1 (274 bp) and p21 Cip1 were studied for (d) LNCaP and (h) PC-3 cells. Total RNA was extracted and semi-quantitative RT-PCR experiments performed to study the expression of p27
Kip1 (274 bp) and p21 Cip1 (206 bp) mRNA using specific primers. b-Actin mRNA expression (212 bp) was used as an internal standard. PCRs were carried out using 1 ml of either a fivefold (cell cycle markers) or 10-fold (bactin) diluted samples of the RT reaction of TRAM-34-or siRNA-treated LNCaP and PC-3 cells. The conditions were as follows: 7 min at 95 1C, then 32-34 cycles of 30-s extension at 72 1C each and a final 7-min extension step. Relative levels of p27
Kip1 and p21 Cip1 mRNA were determined by densitometric analysis of the PCR (p27
Kip1
, p21
Cip1 and b-actin) bands on 1.5% agarose gel and normalized to the b-actin expression rate in each sample. The normalized rate of p27
Kip1 and p21 Cip1 mRNA under control (CTL) conditions was considered to have a value of 1 and the expression rate for TRAM-34-treated cells was compared with that at CTL condition. A representative figure is presented for each experiment, repeated at least twice, in duplicate, and in two independent cell cultures. IK Ca1 , intermediate-conductance calciumactivated potassium channel; RT-PCR, reverse transcription-PCR; siRNA, small interfering RNA. prostate cancer cells were studied by calcium imaging using fura-2 fluorescence. To evaluate membrane hyperpolarization dependence of the CCE in prostate cancer cells, CCE was induced by depleting endoplasmic reticulum Ca 2 þ stores with 1 mM thapsigargin in a Ca 2 þ -free solution. Then, Ca 2 þ was readmitted while the cells were bathed in a solution containing 5.6 mM K þ . Once CCE had been established, solutions containing 50 and 140 mM K þ were applied to depolarize the membrane potential in the LNCaP and PC-3 cells. Each experiment was repeated at least six times in different cell cultures on a field of 25-40 cells and representative experiments are presented. The panels show the mean ± s.e. of 42 cells from two experiments. To study the involvement of IK Ca1 potassium channel functions in passive calcium entry, CCE was induced in LNCaP (c) and PC-3 (d) prostate cancer cells, as described above, in the absence (CTL) or presence of IK Ca1 inhibitor (TRAM-34, 10 mM). The effects of cell transfection with either control siRNA (siCTL) or IK Ca1 -targetted siRNA (siIK Ca1 ) on TG-induced CCE were also studied for (e) LNCaP and (f) PC-3 cells. Each experiment was repeated at least three times in different cell cultures on a field of 25-40 cells and representative experiments are presented. A quantification of the capacitative calcium entry (CCE) for each experiment (c-f) is presented in inset (mean±s.e., n ¼ 45-50 cells), *Po0.01. Periods of TG and KCl applications and extracellular Ca 2 þ increase from 0 (0Ca) to 2 mM (2Ca) are marked by horizontal bars; see text for details. siRNA, small interfering RNA; IK Ca1 , intermediateconductance calcium-activated potassium channel; TG, thapsigargin.
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dose dependent amounting at the highest concentration used (30 mM) at 75 ± 6.5% for LNCaP cells (Figure 4a ) and 50 ± 6.5% for PC-3 cells (Figure 4e ). Similar results were obtained using CLT (1-30 mM), but as this drug is also known to be an antimycotic agent that inhibits fungal P450-dependent enzymes (Ayub and Levell, 1990; Maurice et al., 1992) , its action may not be specific to IK Ca1 . The inactive TRAM-7 (30 mM) did not affect cell proliferation in our studies (data not shown), indicating that the suppressive effect of TRAM-34 was specifically related to IK Ca1 inhibition. The cell arrest induced by TRAM-34 was not due to apoptosis. Indeed, TRAM-34, used at the same concentrations as in the cell proliferation assays, failed to modify the rate of LNCaP cell apoptosis (data not shown). The involvement of IK Ca1 in LNCaP cell proliferation was also studied by using siRNA targeting IK Ca1 in LNCaP (Figure 4c ) and PC-3 (Figure 4g ) cells, and the obtained results were consistent with those obtained with the IK Ca1 inhibitor TRAM-34.
IK Ca1 channel inhibition induces an increase in p21
CIP1 levels We then investigated the mechanism by which IK Ca1 inhibition prevented the proliferation of PCa cells by assaying changes in the expression of p21 CIP1 and p27
Kip1
, cyclin-dependent kinase inhibitors (cdkis), known to act in the G1 phase of the cell cycle (Benito et al., 1998; Ghiani et al., 1999) . In these experiments, LNCaP and PC-3 cells were incubated for 4 days in the culture medium supplemented with either the solvent (dimethyl sulfoxide, control) or various concentrations of TRAM-34, followed by semi-quantitative RT-PCR analysis of p21 CIP1 and p27 Kip1 mRNA expression. Figure 4 shows that a 4-day treatment with TRAM-34 increased p21 CIP1 expression by two-to fourfold (vs CTL) in both LNCaP (Figure 4b ) and PC-3 (Figure 4f ) cells, basically leaving the mRNA rate of p27 Kip1 intact. Similarly, when the expression of the IK Ca1 was knocked down by using IK Ca1 -targetting siRNA, the p21 CIP1 mRNA expression was increased by 2.5-fold (vs siCTL) in both LNCaP (Figure 4d ) and PC-3 (Figure 4h) One of the mechanisms by which the IK Ca1 channel may regulate PCa cell proliferation is calcium entry modulation. To investigate this possibility, we used an established experimental protocol to measure the capacitative calcium entry (CCE) activated by store depletion (Skryma et al., 2000) . We initially investigated whether membrane potential could affect the CCE developed in response to TG (1 mM) by exposing cells to increasing concentrations of KCl (50-140 mM) to depolarize their membrane potential during the development of TG-induced CCE in the presence of 2 mM extracellular Ca 2 þ . As shown in Figure 5 , consecutive applications of 50 and 140 mM KCl and associated membrane depolarizations induced gradual inhibition of CCE in LNCaP (Figure 5a ) and PC-3 (Figure 5b ) PCa cells. To specifically address the issue of the involvement of the IK Ca1 channel in CCE regulation, we used TRAM-34. The application of TG (1 mM) in 0Ca 2 þ medium induced a calcium release from internal stores and the subsequent CCE in 2Ca 2 þ medium in both LNCaP (Figure 5c ) and PC-3 cells (Figure 5d ). In these experiments, when the TRAM-34 (10 mM) was present during the whole experiment, the TG-induced calcium release from intracellular stores was not significantly modified, whereas the amplitude of the CCE was decreased by 71 ± 4.5% (n ¼ 180) in LNCaP cells (Figure 5c , inset) and by 64±6% vs CTL (n ¼ 230) in PC-3 cells (Figure 5d, inset) . Similar results were also obtained with CLT (10 mM) (data not shown), suggesting that IK Ca1 channels regulate CCE by hyperpolarizing membrane potential, thus increasing the electrochemical gradient for calcium. The involvement of IK Ca1 in TGinduced CCE was also confirmed by using siRNA targeting IK Ca1 in calcium imaging experiments performed on LNCaP (Figure 5e ) and PC-3 (Figure 5f ) cells. (Figure 6 ), the cells were superfused with a KCl-free Hank's buffered salt solution (0K þ ) to hyperpolarize them. Application of the 0K þ solution to the cells induced a transient increase in [Ca 2 þ ] i, with a peak amplitude of 500±65 nM from a baseline level of 75±25 nM (n ¼ 250) in LNCaP cells (Figure 6a ) and a peak amplitude of 600 ± 75 nM from 85 ± 25 baseline in PC-3 cells (Figure 6b ). These observations suggested that the increase in the driving force for calcium by membrane hyperpolarization was sufficient to induce calcium entry.
IK Ca1 activation induces an increase in [Ca
To test the direct implication of IK Ca1 activity in controlling basal [Ca 2 þ ]i, the pharmacological activator of the IK Ca1 .(1-EBIO) was used. When 1-EBIO (200 mM) was applied to the cells, a rapid, transient increase in [Ca 2 þ ] i was observed, reaching a maximal value of 550 ± 70 nM (n ¼ 140) in LNCaP cells (Figure 6c ) and 450 ± 50 nM (n ¼ 165) in PC-3 cells (Figure 6d ). To further confirm that the 1-EBIO-induced calcium increase was due to IK Ca1 activation, the same experiments were also conducted in the presence of TRAM-34 (10 mM), an IK Ca1 inhibitor, or in IK Ca1 -knocked down cells using siIK Ca1 . In the presence of TRAM-34 (Figure 6c First, we confirmed TRPV6 expression in these cells by RT-PCR analysis. As shown on the agarose gel presented in Figure 7a , the specific primers for TRPV6 amplified a band of the expected size (255 bp), which had been sequenced earlier and identified as belonging to TRPV6 cDNA.
Next, we designed siRNA against the TRPV6 sequence (siTRPV6), specifically to downregulate its mRNA. As shown in Figure 7b , treating the cells with siTRPV6 (20 nM) for 72 h knocked down the TRPV6 mRNA expression in both LNCaP and PC-3 cells by at least 90-100% (Figure 7b for LNCaP cells), whereas non-targeting siRNA had no effect on TRPV6 mRNA expression. Moreover, the assessment of the effects of IK Ca1 activator 1-EBIO (200 mM) on [Ca 2 þ ] i in LNCaP and PC-3 cells treated with either non-targeting siRNA (siCTL) or specific siTRPV6 showed that the drug was no longer able to induce a calcium increase following TRPV6 downregulation (Figure 7c and d) . This result was consistent with the concept that the [Ca 2 þ ] i rise evoked by IK Ca1 activation was mediated by the TRPV6 cation channel.
IK Ca1 associates with TRPV6 calcium channel
In view of the importance of the TRPV6 calcium channel in the calcium entry evoked by IK Ca1 activation in PCa cells (Figure 7c and d) , we then investigated whether IK Ca1 associated with TRPV6. Co-immunoprecipitation of LNCaP cell extracts by IK Ca1 antibodies and western blot analysis of the immunoprecipitated proteins by TRPV6 antibodies (Figure 7e) showed that IK Ca1 was associated with TRPV6. Similarly, when the LNCaP total protein extract was processed with the anti-TRPV6 antibody for co-immunoprecipitation, immunoblotting using IK Ca1 antibodies identified the IK Ca1 protein among the co-immunoprecipitated proteins (Figure 7e, right panel) . In these experiments, negative controls consisted of incubation of the beads with the cell lysate (without any antibodies) to detect nonspecific adherence of proteins to the beads. When the extracts from siTRPV6-treated LNCaP cells were used, no TRPV6 protein band was observed in the western blot of the IK Ca1 -immunoprecipitated proteins, confirming the specificity of the association between IK Ca1 and TRPV6 channels (data not shown).
The involvement of the IK Ca1 and TRPV6 calcium channels in PCa cell proliferation was then studied by using the siRNA targeting the mRNA of these channels (siIK Ca1 and siTRPV6). When cells were incubated in the presence of either siIK Ca1 (20 nM) or siTRPV6 (20 nM), the cell proliferation was inhibited by 50 ± 6% (siTRPV6) and 60 ± 11% (siIK Ca1 ). In these experiments, when the cells were incubated in both siRNA (siIK Ca1 þ siTRPV6), no additional inhibition of cell proliferation was observed (60 ± 7%) (Figure 7f ) compared with using individual siRNAs. These observations suggest that these ion channels are involved in the same transduction pathway leading to the proliferation of PCa cells.
Discussion
This study reports on the expression, functionality and involvement in proliferation of the IK Ca1 potassium channel in human PCa cells. For the first time, we showed IK Ca1 channel expression at mRNA and protein levels in these cells. Moreover, we showed the essential upregulation of IK Ca1 expression in human PCa vs nonPCa (that is, HBP) tissues and showed that this channel was functional in PCa cell lines as well as primary cultured hPCE cells. This study also showed that IK Ca1 channel is critically involved in the calcium-induced hyperpolarization of the membrane potential of PCa cells.
Using TRAM-34, a specific IK Ca1 inhibitor and IK Ca1 -targetting siRNA, we showed that this channel appears to play an important role in PCa cell proliferation. The involvement of IK Ca1 in cell proliferation has also been shown using other cancer cells, using either CLT or TRAM-34 (Jager et al., 2004) or IK Ca1 -targetting siRNA (Si et al., 2006) . There is evidence that IK Ca1 is upregulated in primary pancreatic cancer tissues (Jager et al., 2004) and that its expression increases in response to mitogenic activation of the Ras/extracellular signal-regulated kinase signaling pathway (Pena et al., 2000) . Our findings are consistent with these observations, as well as providing new evidence of enhanced IK Ca1 expression in human PCa at the mRNA and protein levels. This study also brought substantial evidences in the elucidation of the mechanisms by which IK Ca1 modulates PCa cell growth. The expression of another calcium-activated potassium channel (BK channel) in PCa cells was recently described by Bloch et al. (2007) . In this study, the BK potassium channel was involved in the basal cell proliferation of PC-3 cells but not of LNCaP cells, suggesting that in the LNCaP cells, only IK Ca1 calcium-activated potassium channel is involved, whereas in PC-3 cells, both IK Ca1 and BK channels participate in the modulation of the cell growth.
Cells are known to be depolarized in the early G 1 phase, but hyperpolarized during the progression through G 1 into the S phase (Ghanshani et al., 2000; Kunzelmann, 2005) . K þ -channel inhibition was shown to lead to membrane depolarization and cell-cycle arrest in the early G 1 phase in the MCF-7 human breast carcinoma cell line (Wang et al., 1998) . Conversely, K þ -channel activation promotes cell cycle progression from the G 0 /G1 to S phases (Wonderlin and Strobl, 1996; Ouadid-Ahidouch et al., 2001; Chittajallu et al., 2002) . Here, we showed that IK Ca1 channel inhibition in human PCa cells resulted in growth arrest and an accumulation of p21
Cip1 , but not p27
Kip1 cell cycle regulator. Cell cycle proteins, in particular cdkis that regulate G1 cyclins, are likely to be implicated in withdrawal of the cell cycle. Among these cdkis, p21
Cip1 is involved in cell cycle exit and terminal cell differentiation (Rodrigues et al., 1987) . In agreement with these findings, our results showed that the inhibition of PCa cell growth induced by the IK Ca1 inhibitor was likely to involve the accumulation of p21
Cip1 and cell arrest in the G1 cycle. However, the mechanism by which IK Ca1 channel activity affects the accumulation of cdkis is not known. A recent study shows a correlation between CDK4 expression and activation of the calcium-dependent gene expression pathways involving calcineurin/NFAT (nuclear factor of T lymphocytes) (Baksh et al., 2002) . Recent data suggest the involvement of the S100 calcium-binding proteins in the link between calcium and the expression of p21. The S100 proteins are derived from the expression of 17 genes clustered on human chromosome 1q21, a region frequently rearranged in several types of cancer. Several S100 proteins (S100A2, S100A4 and S100B) are described to be involved positively (S100A2) or negatively (S100A4 and S100B) in the p53-dependent expression of p21. In low intracellular conditions, S100A2 binds p53 to form a transcription factor interacting with p21 promoter to induce the p21 expression. In high intracellular conditions, S100A4 or S100B binds to p53 to inhibit the interaction of the transcription factor with the p21 promoter leading to the suppression of the p53-dependent expression of p21. It was also suggested that a complex of S100A4 with p53 and the sequestration of p53 may result in a stimulation of the cells to enter the S phase by abrogating the control functions of p53 at the G1-S checkpoint perhaps through the modulation of p21 expression (Sherbet and Lakshmi, 1998; Grigorian et al., 2001) . On the other hand, the expression of these S100 proteins was shown to be modulated in human PCa (Gupta et al., 2003) . In these studies, a progressive loss of S100A2 protein was observed in cancer specimens with increasing tumor grade, whereas S100A4 protein was upregulated. This upregulation of S100A4 would be an advantage for PCa cells to inhibit the expression of p21 in the presence of increased intracellular calcium, probably due to enhanced influx through TRPV6 promoted by the activation of IK Ca1 . In this context, inhibiting IK Ca1 channels may induce membrane depolarization, thus reducing the driving force for Ca 2 þ influx, leading to G 0 /G 1 arrest and inhibition of cell proliferation. Therefore, IK Ca1 channel inhibitors show some potential adjuvant chemotherapeutic reagents in anti-PCa therapy.
Cell cycling involves membrane potential hyperpolarization and calcium entry, especially in G1 and the G1/S transition. IK Ca1 channels may be important for keeping the cells hyperpolarized to drive a passive Ca 2 þ influx. Calcium ions regulate virtually all cell processes, including survival, proliferation, apoptosis and differentiation (Berridge et al., 2003; Kunzelmann, 2005) . Intracellular Ca 2 þ is known to play a role in cell proliferation and division in numerous cell types (Tomita et al., 1987; Magnier-Gaubil et al., 1996; Spitzner et al., 2007) including PCa cells (Legrand et al., 2001; Thebault et al., 2003; Thebault et al., 2006) . For example, it has also been shown that calcium signaling is required for cell cycle progression from the G1/S phase through to mitosis (Hazelton et al., 1979; Tupper et al., 1980) . Mitogenesis is accompanied by an increase in intracellular Ca 2 þ , so modifying intracellular Ca 2 þ alters proliferation and mitogenesis (Enomoto et al., 1998; Ducret et al., 2002) .
Using electrophysiological and calcium imaging techniques, we showed that activating the IK Ca1 channels hyperpolarized membrane potential and promoted passive calcium entry in human PCa cell lines, probably by providing or maintaining a sufficiently large driving force for Ca 2 þ entry. This results in the high [Ca 2 þ ] i levels necessary for cell-cycle progression, as proposed by Nilius et al. (1993) . Similar observations were made in the human erythroleukemia cell line, in which it was shown that IK Ca1 channels enhanced Ca 2 þ entry by membrane hyperpolarization (Lu et al., 1999) or in colonic carcinoma cells in which the voltagedependent K þ channel, hEAG, was shown to be implicated in the agonist-induced calcium signaling and cell growth (Spitzner et al., 2007) .
We further identified the TRPV6 calcium channel as a major provider of passive calcium influx in response to the hyperpolarization associated with IK Ca1 channel activation. In an earlier study, we showed the contribution of endogenous TRPV6 to store-operated Ca 2 þ entry in LNCaP cells . A recent study showed the involvement of TRPV6 in the control of PCa LNCaP cell proliferation (Lehen'kyi et al., 2007) . In these studies, the authors showed that the calcium entry through TRPV6 channel in LNCaP cells induced a subsequent downstream activation of NFAT leading to cell proliferation and apoptosis resistance.
Here, we show a novel role for TRPV6 in maintaining the hyperpolarization-evoked Ca 2 þ entry required for cell proliferation. Our data indicated that, when TRPV6 was downregulated in PCa cells (by the use of siRNA), Ca 2 þ influx no longer occurred in response to IK Ca1 activation. Moreover, the immunoprecipitation experiments indicated a close physical interaction between the IK Ca1 and TRPV6 channels in PCa cells, although the type of coupling between them requires further elucidation.
Our immunostaining studies performed on PCa tissues (Figure 1e) show that the IK Ca1 potassium channel appears to be more expressed in the apical side of the cell membrane; however, the expression is present in both apical and basal sides of the acinar cells. TRPV6 channel has been shown earlier to be expressed in the apical membrane of intestinal epithelial cells (van de Graaf et al., 2006) in which it plays a role of the 'Ca 2 þ uptake channel' necessary for the calcium re-absorption. Therefore, it is rather possible that in prostate cells, TRPV6 channel is also expressed on the luminal apical membrane of the secretory epithelial cells. Cell culture models generally fail to preserve many of the characteristics, such as the formation of functional tight junctions and apical and basolateral membrane domains through cell polarization. The latter process is shown to affect the gene expression and the distribution of the membrane proteins at the cell level (Gut et al., 1998; Turowski et al., 2004) . Further studies are needed to identify the distribution of TRPV6 and IK Ca1 in polarized prostate cells and to understand the physiological role of localization of channels.
In conclusion, we showed for the first time that IK Ca1 channels are active players in PCa cells, probably responsible for determining their malignant potential. Upregulation of this channel in PCa vs non-PCa tissues may represent an advantage for cancer cells by promoting an intracellular calcium increase through the TRPV6 channel, also known to be upregulated in PCa (Peng et al., 2001) . In light of these findings, the IK Ca1 channel may be added to the list of potential targets for future PCa therapies.
Materials and methods
Cell culture
LNCaP, PC-3 and DU-145 PCa cell lines, obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), were cultured as described by Gackiere et al. (2006) . Primary PCa epithelial cells (hPCE) were obtained and cultured as described earlier (Bidaux et al., 2005) .
Tissue specimens
Human PCa and BHP biopsies were obtained from consenting patients following the local ethical considerations. All experiments involving patient tissues were carried out under approval number 'CP 01/33', issued by the 'ComiteĆ onsultatif de Protection des Personnes dans la Recherche Biome´dicale de Lille'. For more details, see Supplementary information.
RT-PCR analysis of mRNA expression
Total RNA isolation and RT-PCR experiments were performed as described earlier (Chomczynski and Sacchi, 1987; Roudbaraki et al., 1999) . The PCR primers used in this study, listed in Table 1 (2): CCUG UUCCUGGUUAAAUGC, nt 567-585, accession number NM_002250) using GenePorter transfection reagent (Gene Therapy Systems Inc. (GTS), San Diego, CA, USA) in serumfree Dulbecco's modified Eagle's medium, according to the manufacturer's instructions. The cells were then incubated in RPMI containing 10% fetal calf serum (FCS) for 3 days to downregulate the TRPV6 or IK Ca1 mRNA before use in experiments. The efficiency of both siRNA (1) and (2) to downregulate the siIKCa1 or the TRPV6 was equivalent as verified at the channel expression and functionality level (see Supplementary information, Figures 2 and 3) . The siIK Ca1 (1) and siTRPV6(1) were then used in the studies described in this study.
Western blot analysis and immunoprecipitation
Western blot analysis was performed as described by Vanoverberghe et al. (2004) . For more details, see Supplementary information.
Cell proliferation and apoptosis assays
Cell growth and apoptosis assays were performed as described earlier by Vanoverberghe et al. (2003) . For more details, see Supplementary information.
[Ca 2 þ ]i measurements [Ca 2 þ ] i imaging experiments were performed as described earlier (Gackiere et al., 2006) . For more details, see Supplementary information.
Electrophysiological recordings
Patch-clamp recordings were performed in the whole-cell configuration as described earlier (Mariot et al., 2002) . For more details, see Supplementary information.
Statistical analysis
Plots were produced using Origin 5.0 (Microcal Software Inc., Northampton, MA, USA). Results are expressed as mean±s.e. Statistical analysis was performed using unpaired t-tests or analysis of variance tests followed by either Dunnett (for multiple control versus test comparisons) or StudentNewman-Keuls post-tests (for multiple comparisons). 
